On that other board, people were worrying about dilution of CTIX when they have to eventually issue some new stock to pay for trials and stuff. I compared it to MDVN, which has one drug in development for breast and prostate cancers. MDVN market cap of 3.30 billion bucks; divide that by CTIX's 93.12 shares currently outstanding, if CTIX were valued as highly as MDVN, it would be trading at 36.40.